Innate Pharma SA (IPHA)
1.62
+0.18
(+12.50%)
USD |
NASDAQ |
Apr 14, 16:00
1.62
0.00 (0.00%)
After-Hours: 20:00
Innate Pharma Cash from Investing (TTM) : 8.048M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | -1.373M |
| Cellectis SA | -29.58M |
| Transgene SA | -123.57M |
| Adocia SA | -0.311M |